UK tourists warned after disease that 'kills in 24 hours' found in France and USA

A warning has been issued after a disease that can kill in just 24 hours was found in the US, Norway and France. In recent weeks, France, Norway, the US and the UK have all reported cases of invasive meningococcal disease (IMD).

The disease has been found in people who've travelled to Saudi Arabia for Hajj. In its most recent Communicable Disease Threats Report, the European Centre for Disease Prevention and Control (ECDC) warned: "The case itself did not join on the travellers and it is not possible to rule out other potential exposure."

Up to 10 per cent of meningococcal disease can result in death, according to the charity Meningitis Now. Symptoms include fever and/or vomiting and being very sleepy, vacant or difficult to wake, as well as being confused or delirious too.

READ MORE Met Office issue verdict on when heatwaves will hit UK in June and July

Other signs could be a rash, which can be anywhere on the body. Additional symptoms of meningitis include a severe headache and also seizures as well as a dislike of bright lights and also a stiff neck Additional symptoms of septicaemia include breathing fast/breathlessness.

Pale or mottled skin, limb/muscle/joint pain, which may come with stomach pain or diarrhoea and cold hands, feet or shivering have all also been listed. Dr Dipti Patel, Director of NaTHNaC, said: "Our comprehensive fact sheet offers vital information on health regulations, vaccine requirements and recommendations, and general health advice for Hajj and Umrah pilgrims. Please adhere to our guidance for a safe journey."

Dr Salman Waqar, GP and President of the British Islamic Medical Association, said: "We wish all pilgrims a safe and successful trip. Adhering to public health guidance on staying safe and healthy will help facilitate an easier Hajj. Travellers are especially reminded to observe good hand hygiene, have up to date vaccinations, and where necessary discuss the management of pre-existing conditions with their medical teams before departure."